Home / Generics

Generics

News

Generics of apixaban and chlorzoxazone approved in EU and US posted 03/07/2020

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended a generic version...

Aurobindo Pharma receives FDA approval for three generics posted 12/06/2020

India-based generics maker Aurobindo Pharma (Aurobindo) has received three approvals from the US Food and Drug Administration...

COVID-19 drugs: Gilead’s remdesivir and Algernon’s alternative posted 22/05/2020

Gilead Sciences has signed licensing agreements with five generics manufacturers based in India and Pakistan to increase prod...

FDA approves Proventil and Daraprim generics posted 12/05/2020

The US Food and Drug Administration (FDA) has approved the first generic version of a commonly used inhaler, marketed as Prov...

FDA approves lung cancer and anticoagulant generics posted 20/03/2020

The US Food and Drug Administration (FDA) has issued a final approval for a generic version of Alimta (pemetrexed) and two ne...

 

Research

Differences in originator and generic drug labels: impact on patient safety posted 26/06/2020

The labels for established generics and their originators differ. Especially when it comes to safety messaging, these differe...

Generics substitution in Finland: a pharmacy customer perspective posted 24/06/2020

Generics offer less expensive alternatives to brand-name drugs. However, they must be accepted by patients to increase uptake...

US policy to combat high-priced generics posted 29/05/2020

The cost of prescription drugs is a concern in the US. Drug prices typically decline once a generic drug is approved due to m...

Why does the US face high-priced generics and drug shortages? posted 22/05/2020

Healthcare budgets in the US are under strain and the cost of prescription drugs is a continuous concern. Generic drugs offer...

Comparison of economic loss between generics and patented drugs in Indonesia posted 17/04/2020

Poor management of the drug inventory in hospitals can be caused by stagnant and stock-out conditions, which might lead to ec...

 

General

HIV drug Kaletra appears on Russian black market posted 12/06/2020

There are several reports of a black market in Russia emerging for the HIV drug Kaletra, following claims that it can be used...

CMS proposes new measures to rate generic usage posted 07/05/2020

The Centers for Medicare & Medicaid Services (CMS) is actively working to promote competition and lower costs for drugs,...

Science, outreach, development: US Generics Drugs Office reaches new highs in 2019 posted 24/04/2020

The US Food and Drug Administration (FDA) Office of Generic Drugs 2019 Annual report gave updates on the number of generics a...

Improving the pathway for generics approval in the US: 2019 update posted 24/04/2020

The US Food and Drug Administration’s (FDA) Office of Generic Drugs released their 2019 annual report in February 2020. This...

Generics approvals remain high in US in 2019 posted 24/04/2020

In February 2020, the US Food and Drug Administration’s (FDA) Office of Generic Drugs released their 2019 Annual report which...